Consensus statement on the application of rtms in depression in the netherlands and Belgium

M. Arns, C. Bervoets, P. van Eijndhoven, C. Baeken, O. A. van den Heuvel, A. Aleman, D. J. L. G. Schutter, Y. van der Werf, S. van Belkum, I. E. Sommer, R. van Ruth, B. Haarman, J. Spijker, A. T. Sack

Research output: Contribution to journalReview articleProfessional

Abstract

BACKGROUND Since 2017, repetitive transcranial magnetic stimulation (rtms) has become eligible for reimbursement for the treatment of therapy-resistant depression in the Dutch healthcare system. AIM To initiate a guideline in the Netherlands and Belgium for the safe and effective application of rtms for the treatment of depression. METHOD Based on literature review, existing guidelines and consensus among Dutch rtms experts, recommendations were developed regarding the implementation of rtms as a treatment of depression. All available evidence was weighed and discussed among all co-authors and recommendations were reached by consensus among the group. RESULTS rtms targeting the dorsolateral prefrontal cortex (dlpfc) should be seen as a first choice in the treatment of depression using high-frequency rtms (left) or, as an alternative, low-frequency rtms (right). Stimulation protocols should use more than 1000 pulses per session for an average of 20-30 sessions, offered in 2-5 sessions per week. Contraindications for rtms include epilepsy, intracranial presence of (magnetisable) metals, pacemaker and cochlear implant. CONCLUSION rtms, performed by competent professionals is an effective and safe treatment for depression.
Translated title of the contributionConsensus statement on the application of rtms in depression in the netherlands and Belgium
Original languageDutch
Pages (from-to)411-420
Number of pages10
JournalTijdschrift voor Psychiatrie
Volume61
Issue number6
Publication statusPublished - 1 Jan 2019

Cite this

Arns, M., Bervoets, C., van Eijndhoven, P., Baeken, C., van den Heuvel, O. A., Aleman, A., ... Sack, A. T. (2019). Consensusverklaring voor de toepassing van rtms bij depressie in nederland en belgie. Tijdschrift voor Psychiatrie, 61(6), 411-420.
Arns, M. ; Bervoets, C. ; van Eijndhoven, P. ; Baeken, C. ; van den Heuvel, O. A. ; Aleman, A. ; Schutter, D. J. L. G. ; van der Werf, Y. ; van Belkum, S. ; Sommer, I. E. ; van Ruth, R. ; Haarman, B. ; Spijker, J. ; Sack, A. T. / Consensusverklaring voor de toepassing van rtms bij depressie in nederland en belgie. In: Tijdschrift voor Psychiatrie. 2019 ; Vol. 61, No. 6. pp. 411-420.
@article{e5cb2103c05d462c9871ceac5ef08b36,
title = "Consensusverklaring voor de toepassing van rtms bij depressie in nederland en belgie",
abstract = "BACKGROUND Since 2017, repetitive transcranial magnetic stimulation (rtms) has become eligible for reimbursement for the treatment of therapy-resistant depression in the Dutch healthcare system. AIM To initiate a guideline in the Netherlands and Belgium for the safe and effective application of rtms for the treatment of depression. METHOD Based on literature review, existing guidelines and consensus among Dutch rtms experts, recommendations were developed regarding the implementation of rtms as a treatment of depression. All available evidence was weighed and discussed among all co-authors and recommendations were reached by consensus among the group. RESULTS rtms targeting the dorsolateral prefrontal cortex (dlpfc) should be seen as a first choice in the treatment of depression using high-frequency rtms (left) or, as an alternative, low-frequency rtms (right). Stimulation protocols should use more than 1000 pulses per session for an average of 20-30 sessions, offered in 2-5 sessions per week. Contraindications for rtms include epilepsy, intracranial presence of (magnetisable) metals, pacemaker and cochlear implant. CONCLUSION rtms, performed by competent professionals is an effective and safe treatment for depression.",
author = "M. Arns and C. Bervoets and {van Eijndhoven}, P. and C. Baeken and {van den Heuvel}, {O. A.} and A. Aleman and Schutter, {D. J. L. G.} and {van der Werf}, Y. and {van Belkum}, S. and Sommer, {I. E.} and {van Ruth}, R. and B. Haarman and J. Spijker and Sack, {A. T.}",
year = "2019",
month = "1",
day = "1",
language = "Dutch",
volume = "61",
pages = "411--420",
journal = "Tijdschrift voor Psychiatrie",
issn = "0303-7339",
publisher = "Uitgeverij Boom",
number = "6",

}

Arns, M, Bervoets, C, van Eijndhoven, P, Baeken, C, van den Heuvel, OA, Aleman, A, Schutter, DJLG, van der Werf, Y, van Belkum, S, Sommer, IE, van Ruth, R, Haarman, B, Spijker, J & Sack, AT 2019, 'Consensusverklaring voor de toepassing van rtms bij depressie in nederland en belgie' Tijdschrift voor Psychiatrie, vol. 61, no. 6, pp. 411-420.

Consensusverklaring voor de toepassing van rtms bij depressie in nederland en belgie. / Arns, M.; Bervoets, C.; van Eijndhoven, P.; Baeken, C.; van den Heuvel, O. A.; Aleman, A.; Schutter, D. J. L. G.; van der Werf, Y.; van Belkum, S.; Sommer, I. E.; van Ruth, R.; Haarman, B.; Spijker, J.; Sack, A. T.

In: Tijdschrift voor Psychiatrie, Vol. 61, No. 6, 01.01.2019, p. 411-420.

Research output: Contribution to journalReview articleProfessional

TY - JOUR

T1 - Consensusverklaring voor de toepassing van rtms bij depressie in nederland en belgie

AU - Arns, M.

AU - Bervoets, C.

AU - van Eijndhoven, P.

AU - Baeken, C.

AU - van den Heuvel, O. A.

AU - Aleman, A.

AU - Schutter, D. J. L. G.

AU - van der Werf, Y.

AU - van Belkum, S.

AU - Sommer, I. E.

AU - van Ruth, R.

AU - Haarman, B.

AU - Spijker, J.

AU - Sack, A. T.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - BACKGROUND Since 2017, repetitive transcranial magnetic stimulation (rtms) has become eligible for reimbursement for the treatment of therapy-resistant depression in the Dutch healthcare system. AIM To initiate a guideline in the Netherlands and Belgium for the safe and effective application of rtms for the treatment of depression. METHOD Based on literature review, existing guidelines and consensus among Dutch rtms experts, recommendations were developed regarding the implementation of rtms as a treatment of depression. All available evidence was weighed and discussed among all co-authors and recommendations were reached by consensus among the group. RESULTS rtms targeting the dorsolateral prefrontal cortex (dlpfc) should be seen as a first choice in the treatment of depression using high-frequency rtms (left) or, as an alternative, low-frequency rtms (right). Stimulation protocols should use more than 1000 pulses per session for an average of 20-30 sessions, offered in 2-5 sessions per week. Contraindications for rtms include epilepsy, intracranial presence of (magnetisable) metals, pacemaker and cochlear implant. CONCLUSION rtms, performed by competent professionals is an effective and safe treatment for depression.

AB - BACKGROUND Since 2017, repetitive transcranial magnetic stimulation (rtms) has become eligible for reimbursement for the treatment of therapy-resistant depression in the Dutch healthcare system. AIM To initiate a guideline in the Netherlands and Belgium for the safe and effective application of rtms for the treatment of depression. METHOD Based on literature review, existing guidelines and consensus among Dutch rtms experts, recommendations were developed regarding the implementation of rtms as a treatment of depression. All available evidence was weighed and discussed among all co-authors and recommendations were reached by consensus among the group. RESULTS rtms targeting the dorsolateral prefrontal cortex (dlpfc) should be seen as a first choice in the treatment of depression using high-frequency rtms (left) or, as an alternative, low-frequency rtms (right). Stimulation protocols should use more than 1000 pulses per session for an average of 20-30 sessions, offered in 2-5 sessions per week. Contraindications for rtms include epilepsy, intracranial presence of (magnetisable) metals, pacemaker and cochlear implant. CONCLUSION rtms, performed by competent professionals is an effective and safe treatment for depression.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85068858781&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/31243751

M3 - Review article

VL - 61

SP - 411

EP - 420

JO - Tijdschrift voor Psychiatrie

JF - Tijdschrift voor Psychiatrie

SN - 0303-7339

IS - 6

ER -

Arns M, Bervoets C, van Eijndhoven P, Baeken C, van den Heuvel OA, Aleman A et al. Consensusverklaring voor de toepassing van rtms bij depressie in nederland en belgie. Tijdschrift voor Psychiatrie. 2019 Jan 1;61(6):411-420.